Project Phoenix: Commercial Due Diligence on an Animal Health Listco

Two phases of commercial due diligence for one of the largest take private transactions in Europe (deal size $5bn+), as well as follow on value creation strategy

➢ 1st phase: outside in due diligence of the target (listed veterinary pharmaco)

➢ 2nd phase: coordination of due diligence effort amongst multiple advisors, working closely with bankers and financing parties alongside client

➢ Portfolio phase to enable digitally enhanced field force and pipeline acceleration

Previous
Previous

Project Enterprise: Commercial Transformation for a Global Health Insurance Player

Next
Next

Project Health: Fund Strategy for a ~€3bn Life Sciences Growth Fund